Enochian responded to the arrest of Gumrukçu on May 25 with a statement from its board asserting that it only learned of his arrest from DoJ’s press release; that the murder-for-hire occurred before the February 2018 completion of Enochian’s acquisition by DanDrit Biotech USA “and is completely unrelated to the company.” The board added that it "strongly affirms its confidence in the company’s promising future . . .
